Biodegradable Starch Microspheres (Spherex), a Clinically Useful Medical Device for Combined Intra-Arterial Chemotherapeutic Treatment of Primary and Metastatic Cancers of the Liver: The Potential Clinical Value for Spherex in Regionalized Immunotherapy, Hyperthermia and Radiation Protection

[1]  J. Guy,et al.  Hepatic artery ligation and portal vein infusion for liver metastases from colon cancer. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  J. Byfield,et al.  Treatment with combined intraarterial 5‐FUdR infusion and whole‐liver radiation for colon carcinoma metastatic to the liver Preliminary results , 1984, American journal of clinical oncology.

[3]  N. Kemeny,et al.  Long-term hepatic arterial infusion chemotherapy. Anatomic considerations, operative technique, and treatment morbidity. , 1984, Archives of surgery.

[4]  J. Thrall,et al.  Regional chemotherapy of colorectal cancer metastatic to the liver , 1984, Cancer.

[5]  J. Fortner,et al.  Multivariate Analysis of a Personal Series of 247 Patients with Liver Metastases from Colorectal Cancer: II. Treatment by Intrahepatic Chemotherapy , 1984, Annals of surgery.

[6]  J. Thrall,et al.  Quantitative hepatic arterial perfusion scintigraphy and starch microspheres in cancer chemotherapy. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  J. Niederhuber,et al.  Improved regional selectivity of hepatic arterial mitomycin by starch microspheres , 1983, Clinical pharmacology and therapeutics.

[8]  S. Wallace,et al.  Hepatic arterial chemotherapy and occlusion for palliation of primary hepatocellular and unknown primary neoplasms in the liver , 1983, Cancer.

[9]  Y. Lee.  Regional management of liver metastases. I. , 1983, Cancer investigation.

[10]  S. Dakhil,et al.  Improved regional selectivity of hepatic arterial bcnu with degradable microspheres , 1982, Cancer.

[11]  J. Thrall,et al.  Totally implanted drug delivery system for hepatic arterial chemotherapy. , 1981, Cancer treatment reports.

[12]  S. Wallace,et al.  THE PALLIATIVE ROLE OF HEPATIC ARTERIAL INFUSION AND ARTERIAL OCCLUSION IN COLORECTAL CARCINOMA METASTATIC TO THE LIVER , 1981, The Lancet.

[13]  L. Hillered,et al.  Kidney radioprotection by temporary hypoxia. Experiments with degradable microspheres. , 1981, Scandinavian journal of urology and nephrology.

[14]  S. Wallace,et al.  Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): An effective treatment for metastatic colorectal carcinoma in the liver , 1980, Cancer.

[15]  S. Moss,et al.  Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil versus intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer: A Central Oncology Group study. , 1979, Surgery.

[16]  R. Tuma,et al.  The trapping of drugs in the microcirculation with degradable microspheres. , 1979, Bibliotheca anatomica.

[17]  R. Tuma,et al.  Biospheres--a tool to induce transient ischemia in experimental medicine as studied in the kidney. , 1979, Bibliotheca anatomica.

[18]  U. Rothman,et al.  Controlled blocking of hepatic artery flow with enzymatically degradable microspheres combined with oncolytic drugs. , 1979, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.

[19]  H. Jiborn,et al.  Protective effect of hypoxia against radiation induced fibrosis in the rat gut. , 1979, Acta radiologica: oncology, radiation, physics, biology.

[20]  D. Levin,et al.  A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil. , 1978, Cancer research.

[21]  L. Fielding.  Adjuvant liver perfusion in colorectal cancer. , 1978, British medical journal.

[22]  U. Rothman,et al.  Studies in Pharmacokinetics and Tolerance of Substances Temporarily Retained in the Liver by Microsphere Embolization , 1978, Annals of surgery.

[23]  Forsberg Jo.  Transient blood flow reduction induced by intra-arterial injection of degradable starch microspheres. Experiments on rats. , 1978 .

[24]  J. O. Forsberg,et al.  Radiation response modified by degradable starch microspheres. Experiments on the rat's foot. , 1978, Acta radiologica: oncology, radiation, physics, biology.

[25]  J. O. Forsberg,et al.  Mucosal protection during irradiation of exteriorized rat ileum. Effect of hypoxia induced by starch microspheres. , 1978, Acta radiologica: oncology, radiation, physics, biology.

[26]  J. O. Forsberg,et al.  Abdominal radiation response modified by hypoxia after intra-aortal injection of starch microspheres. Experiments in the rat. , 1978, Acta radiologica: oncology, radiation, physics, biology.

[27]  I. Taylor,et al.  Adjuvant liver perfusion in colorectal cancer: initial results of a clinical trial. , 1977, British medical journal.

[28]  H. O. Sjögren,et al.  The circulation in liver tissue and experimental liver metastases before and after embolization of the liver artery , 1977, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

[29]  U. Rothman,et al.  Repeated arterial embolization of rat livers by degradable microspheres. , 1977, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.

[30]  D. Morton,et al.  Hepatic artery ligation and 5-fluorouracil infusion for metastatic colon carcinoma and primary hepatoma. , 1976, American journal of surgery.

[31]  D. Lewis,et al.  Temporary intestinal hypoxia induced by degradable microspheres , 1976, Nature.

[32]  B. Gustavsson,et al.  Results of regional portal infusion of 5-fluorouracil in patients with primary and secondary liver cancer. , 1976, Annales chirurgiae et gynaecologiae.

[33]  P. Sipponen,et al.  The effect of hepatic dearterialization and re-dearterialization on carcinoid liver metastases. , 1976, Annales chirurgiae et gynaecologiae.

[34]  M. Kairaluoma,et al.  Evaluation of the ligation of the hepatic artery and regional arterial chemotherapy in the treatment of primary and secondary cancer of the liver. , 1975, Annales chirurgiae et gynaecologiae Fenniae.

[35]  S. Bengmark,et al.  Present experiences with hepatic dearterialization in liver neoplasm. , 1974, Progress in surgery.

[36]  B. Cady,et al.  Regional infusion chemotherapy of hepatic metastases from carcinoma of the colon. , 1974, American journal of surgery.

[37]  R. Mulcare,et al.  Treatment of Primary and Secondary Liver Cancer by Hepatic Artery Ligation and Infusion Chemotherapy , 1973, Annals of surgery.

[38]  R. Condon,et al.  Hepatic artery ligation and cytotoxic infusion in treatment of liver metastases. , 1972, Archives of surgery.

[39]  C. Rudenstam,et al.  Evaluation of hepatic dearterialization in primary and secondary cancer of the liver. , 1972, American journal of surgery.

[40]  L. Blendis,et al.  Treatment of secondary hepatic tumours by ligation of hepatic artery and infusion of cytotoxic drugs. , 1970, Lancet.

[41]  S. Bengmark,et al.  Angiographic study of the collateral circulation to the liver after ligation of the hepatic artery in man. , 1970, American journal of surgery.

[42]  E. Watkins,et al.  Surgical basis for arterial infusion chemotherapy of disseminated carcinoma of the liver. , 1970, Surgery, gynecology & obstetrics.

[43]  E. Watkins,et al.  CHEMOTHERAPY OF METASTATIC LIVER CANCER BY PROLONGED HEPATIC-ARTERY INFUSION. , 1964, The New England journal of medicine.

[44]  P. Kuehn,et al.  Effects of continuous hepatic artery infusion of antimetabolites on primary and metastatic cancer of the liver , 1962, Cancer.

[45]  C. Breedis,et al.  The blood supply of neoplasms in the liver. , 1954, The American journal of pathology.

[46]  A. Rappaport,et al.  Prevention of Liver Necrosis following Ligation of Hepatic Artery , 1949, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[47]  M. Berger,et al.  Treatment of prostatic cancer with alpha-bromo-alpha beta. beta-triphenylethylene (Y59). , 1947, Lancet.

[48]  A. Melville.  A Case of Absence of the Gall Bladder and Duodenal Diverticulosis , 1937 .